deltatrials
Unknown NA INTERVENTIONAL 2-arm NCT04583436

Efficacy and Safety Comparison of the Open and Endovascular Surgical Methods for the Treatment of Long Atherosclerotic Lesions of the Femoral-popliteal Segment Below the Knee, TASC D in Patients With Critical Limb Ischemia

Efficacy and Safety Comparison of the Open (Femoral-popliteal Distal Bypass by Synthetic Vascular Graft) and Endovascular (Recanalization With Angioplasty and Stenting With Biomimetic Interwoven Nitinol Stent) Surgical Methods for the Treatment of Long Atherosclerotic Lesions of the Femoral-popliteal Segment Below the Knee, TASC D in Patients With Critical Limb Ischemia

Sponsor: Meshalkin Research Institute of Pathology of Circulation

Updated 6 times since 2020 Last updated: Oct 5, 2020 Started: Sep 1, 2020 Primary completion: Sep 1, 2024 Completion: Oct 1, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Atherosclerotic Ischemic Disease and Critical Limb Ischemia and is currently ongoing. Meshalkin Research Institute of Pathology of Circulation leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – ~Sep 2025 · 10 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotUnknown

Change History

6 versions recorded
  1. Sep 2025 — Present [monthly]

    Unknown NA

  2. Nov 2024 — Sep 2025 [monthly]

    Unknown NA

    Status: RecruitingUnknown

  3. Sep 2024 — Nov 2024 [monthly]

    Recruiting NA

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  5. Jan 2021 — Jul 2024 [monthly]

    Recruiting NA

Show 1 earlier version
  1. Nov 2020 — Jan 2021 [monthly]

    Recruiting NA

    First recorded

Sep 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Meshalkin Research Institute of Pathology of Circulation
Data source: Meshalkin Research Institute of Pathology of Circulation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations